Ask AI
ProCE Banner Activity

Expert Insights on Aligning Early Advanced IBD Therapy in Real-world Practice

Podcast

Listen in as 4 inflammatory bowel disease (IBD) experts explore case-based strategies for optimizing advanced IBD therapy and long-term disease management early in real-world practice. They discuss practical approaches for implementing treat-to-target via strategic treatment sequencing, therapeutic drug monitoring, and maintenance approaches while supporting individualized, evidence-based care for patients with IBD.

Released: July 30, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education, in partnership with Smart Patients

ProCE Banner

Supporters

Supported by an independent educational grant from AbbVie.

AbbVie

Partners

Smart Patients

ProCE Banner

Target Audience

This activity is intended for gastroenterologists, nurse practitioners (NPs), physician associates (PAs), and other HCPs who manage patients with IBD.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appraise newer advanced therapies in Crohn’s disease according to recent safety and efficacy evidence

  • Evaluate recent evidence for newer advanced therapies for ulcerative colitis

  • Formulate personalized IBD treatment plans in alignment with the latest guidelines, recent evidence, and patient preferences

  • Identify patients with suboptimal IBD disease control who would benefit from treatment advancement

Financial Disclosures

Primary Author

Jessica Allegretti, MD, MPH, FACG, AGAF: consultant/advisor/speaker: AbbVie, Celltrion, Curogen, Ferring, Genentech, GSK, Janssen, MetaGen, Pfizer, Shattuck Labs, TRexBio, Vedanta, Xencor.

Jordan E. Axelrad, MD, MPH, AGAF, FACG, FCCF: researcher: Genentech, Johnson & Johnson, Takeda; consultant/advisor/speaker: AbbVie, Abivax, Adiso, bioMérieux, Bristol Myers Squibb, Celltrion, Ferring, Fresenius, Johnson & Johnson, Lilly, Merck, Sanofi, Pfizer, Takeda, Vedanta.

Russell D. Cohen, MD, FACG, AGAF: consultant/advisor/speaker: AbbVie, Genentech, Gilead, Johnson & Johnson, Lilly, Pfizer, Takeda.

Amy Stewart, MSN, FNP-C: consultant/advisor/speaker: AbbVie, Celltrion, Exact Sciences, Johnson & Johnson, Lilly, Merck, Mindset Health, Nestle Health Sciences, Pfizer, Phathom, Prometheus, Salix, Sanofi, Takeda.

Additional Disclosures

Generative artificial intelligence (AI) tools were used for drafting educational content. All AI-assisted content underwent human review, editing, and validation by qualified faculty and accredited education staff to ensure scientific accuracy, balance, and compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education.